【24h】

Testosterone replacement therapy in the ageing man

机译:老年男性的睾丸激素替代疗法

获取原文
获取原文并翻译 | 示例
       

摘要

The benefits of testosterone replacement therapy (TRT) for men suffering from hypogonad-ism of organic origin are well established. Many symptoms of male ageing are common to hypogonadism, which led to the speculation they could result from the partial hypogonadism often observed after 50 years of age. Whether there is a cause and effect relation and a significant benefit of TRT at this age is however still a matter of debate. To clarify this issue we reviewed the 43 double-blind, placebo-controlled, randomized trials that we found in the literature in which men of mean age >50 years with baseline testosterone low to low normal with respect to the normal young adult range (<50 years old) testosterone were treated with testosterone (T) preparations [1]. Most of these trials can be found in recent comprehensive reviews [2-4].
机译:睾丸激素替代疗法(TRT)对于患有器质性性腺机能减退症的男性的益处已得到广泛证实。男性性腺功能减退症有许多男性衰老的常见症状,这导致人们推测它们可能是由于50岁以后经常观察到的部分性腺功能减退症所致。然而,在这个年龄段,TRT是否存在因果关系和显着的收益仍是一个争论的问题。为了澄清这个问题,我们回顾了文献中发现的43项双盲,安慰剂对照,随机试验,其中平均年龄> 50岁且基线睾丸激素水平相对于正常年轻成年人范围较低(< 50岁)的睾丸激素采用睾丸激素(T)制剂治疗[1]。这些试验中的大多数都可以在最近的综合评论中找到[2-4]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号